Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for Postoperative Delirium After Knee Arthroplasty
NCT03629483Phase 4Terminated
- Sponsor
- Peking University First Hospital
- Start
- Dec 2018
- Primary completion
- Dec 2018
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial of dexmedetomidine in postoperative delirium (POD), sponsored by Peking University First Hospital. Primary endpoint: Incidence of delirium during the first 3 days after surgery. Started Dec 2018; status: terminated.
02
Drugs
dexmedetomidine
03
Conditions
postoperative delirium (POD)
Beyond the preview
Go deeper on NCT03629483.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03629483.